SUN PHARMA ADV.RES.CO.LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of SPARC for the last quarter is 168.10 M INR, and it's 1.51% higher compared to the previous quarter. The net income of Q1 24 is -959.00 M INR.